Global Hydrocephalus Shunts Market Size

Hydrocephalus Shunts Market Analysis

The hydrocephalus shunts market is expected to register a CAGR of 8% during the forecast period.

The world has been facing the huge threat of COVID-19. As per the World Health Organization (WHO), COVID-19 is infectious, and most people infected by the virus experience mild to moderate respiratory illness. The COVID-19 outbreak had a significant impact on the hydrocephalus shunts market. The lockdown measures across the world resulted in decreased public mobility. They also impacted the clinical R&D studies and surgeries, as the procedures that were non-immediate were postponed to decrease the burden on healthcare infrastructure. As per the study published by the Neurology Online Journal, in 2020, COVID-19 could potentially be responsible for the patients developing new neurological disorders. The increase in new disorders resulted in a higher risk of in-hospital mortality and decreased likelihood of being discharged sooner. The study closely monitored 606 adult COVID-19 patients diagnosed with brain or other nerve-related medical conditions at any point of their infection. The injuries incurred ranged from temporary confusion due to low body-oxygen levels to stroke and seizures in serious cases. Such factors may positively influence the market studied.

The market's growth is attributed to the growing geriatric population, a rising prevalence of brain and neurological disorders, and the increasing adoption of advanced programmable valves. Neurosurgeons are inclining toward the latest technology shunts, antisiphon devices, and advanced programmable valves. Antisiphone devices help in avoiding siphon effects over cerebrospinal fluid. The increasing prevalence of brain disorders is leading to high demand for advanced shunts for treating hydrocephalus. For instance, according to an article published by the American Society for Biochemistry and Molecular Biology in March 2021, in the United States, about 2.8 million people sustain a traumatic brain injury (TBI) every year, with some 280,000 resulting in hospitalizations. Approximately 50,000 are fatal cases causing 155 deaths every day from TBI-related injuries, which are contributing to the market's growth. Product launches, product approvals, and an increased focus by several players on expanding product portfolios in neurosurgery are anticipated to boost the hydrocephalus shunts market. However, issues regarding the infections caused using hydrocephalus shunts may hamper the market's growth.